You have 9 free searches left this month | for more free features.

Blood-Stage

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Plasmodium Vivax Infection Trial in Bangkok (An inoculum of malaria parasitised red blood cells with whole dose blood-stage

Recruiting
  • Plasmodium Vivax Infection
  • An inoculum of malaria parasitised red blood cells with whole dose blood-stage inoculum
  • +3 more
  • Bangkok, Thailand
    Faculty of Tropical Medicine
Jun 21, 2022

Malaria,Falciparum Trial in Sigle (Rabies vaccine, RH5.1 10µg adjuvated with 50µg Matrix-M, RH5.2 5µg adjuvated with 50µg

Recruiting
  • Malaria,Falciparum
  • Rabies vaccine
  • +2 more
  • Sigle, Boulkiemdé Province, Burkina Faso
    Institut de Recherche en Sciences de la Santé
Apr 3, 2023

Malaria Trial run by the NIAID (HMPBS02-Pv)

Active, not recruiting
  • Malaria
  • HMPBS02-Pv
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 5, 2022

Malaria,Falciparum, Malaria, Malaria Recrudescence Trial in Brisbane (Pyronaridine, P. falciparum IBSM infection)

Completed
  • Malaria,Falciparum
  • +5 more
  • Brisbane, Queensland, Australia
  • +1 more
Nov 3, 2022

Infections, Vector Borne Diseases, Systemic Inflammatory Response Syndrome Trial in Brisbane (MMV367, P. falciparum IBSM

Recruiting
  • Infections
  • +11 more
  • MMV367
  • P. falciparum IBSM infection
  • Brisbane, Queensland, Australia
  • +1 more
Jul 30, 2023

Malaria, Plasmodium Falciparum Trial in Bagamoyo (P. falciparum infected erythrocytes)

Not yet recruiting
  • Malaria
  • Plasmodium Falciparum
  • P. falciparum infected erythrocytes
  • Bagamoyo, Tanzania
    Ifakara Health Institute
May 26, 2022

Malaria, Falciparum Trial in Oxford (Matrix M with R78C and/or RH5.1)

Not yet recruiting
  • Malaria, Falciparum
  • Matrix M with R78C and/or RH5.1
  • Oxford, United Kingdom
    CCVTM, University of Oxford, Churchill Hospital
May 26, 2022

Malaria, Plasmodium Falciparum Trial (Matrix-M with RH5.2 VLP and/or R21)

Not yet recruiting
  • Malaria, Plasmodium Falciparum
  • Matrix-M with RH5.2 VLP and/or R21
  • (no location specified)
Oct 21, 2022

Malaria, Vivax Trial in Oxford (PvDBPII/Matrix-M1)

Recruiting
  • Malaria, Vivax
  • PvDBPII/Matrix-M1
  • Oxford, United Kingdom
    CCVTM, University of Oxford, Churchill Hospital
Feb 8, 2022

Plasmodium Vivax Infection, Malaria Vaccine Trial in Bangkok (Malaria Vaccine, HBV vaccine)

Not yet recruiting
  • Plasmodium Vivax Infection
  • Malaria Vaccine
  • Malaria Vaccine
  • HBV vaccine
  • Bangkok, Thailand
    Faculty of Tropical Medicine
Jan 16, 2023

LIver, Biliary tRAct and pancReatic Cancers

Recruiting
  • Liver Cancer
  • +2 more
  • Blood drawing
  • Hangzhou, Zhejiang, China
    The Second Affiliated Hospital, Zhejiang University School of Me
Nov 14, 2023

Resistant Arterial Hypertension Trial in Ryazan (Blood samples will be taken for pharmacokinetics and pharmacogenetics)

Recruiting
  • Resistant Arterial Hypertension
  • Blood samples will be taken for pharmacokinetics and pharmacogenetics
  • Ryazan, Russian Federation
    Ryzan State Medical University
Jun 1, 2023

Malaria,Falciparum Trial in Bagamoyo (RH5.1/Matrix-M)

Enrolling by invitation
  • Malaria,Falciparum
  • RH5.1/Matrix-M
  • Bagamoyo, Tanzania
    Ifakara Health Institute Clinical Trial Facility
Oct 21, 2022

Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma Trial (Liquid Biopsy)

Not yet recruiting
  • Hepatocellular Carcinoma
  • +4 more
  • Liquid Biopsy
  • (no location specified)
Apr 18, 2023

GAMAD for Early-stage HCC Based on Circulating Tumor DNA

Not yet recruiting
  • Hepatocellular Carcinoma
  • GAMAD
  • (no location specified)
Nov 22, 2022

Malaria Trial in London, Southampton (RH5.1/ ASO1)

Completed
  • Malaria
  • RH5.1/ ASO1
  • London, United Kingdom
  • +1 more
Dec 6, 2021

Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7, Stage IIIB Cutaneous Melanoma AJCC v7 Trial in

Active, not recruiting
  • Stage III Cutaneous Melanoma AJCC v7
  • +4 more
  • Cryosurgery
  • +3 more
  • Rochester, Minnesota
    Mayo Clinic
Jan 3, 2023

Cancer Colorectal Trial (a multi-locus blood-based assay)

Not yet recruiting
  • Cancer Colorectal
  • a multi-locus blood-based assay
  • (no location specified)
Sep 7, 2022

Fibrinogen and Intraoperative Bleeding in Liver Transplant

Completed
  • End Stage Liver DIsease
  • Liver Transplant; Complications
    • Montréal, Quebec, Canada
      Centre Hospitalier de l'Université de Montréal (CHUM)
    Nov 24, 2022

    Chronic Kidney Disease stage3 Trial (Blood samples)

    Not yet recruiting
    • Chronic Kidney Disease stage3
    • Blood samples
    • (no location specified)
    Aug 30, 2023

    Alcohol Use, Alcohol Drinking, Drinking Behavior Trial in Boston (Alcohol-related mobile health technologies, Motivational

    Recruiting
    • Alcohol Use
    • +2 more
    • Alcohol-related mobile health technologies
    • Motivational interview and psychoeducation on blood/breath alcohol concentration
    • Boston, Massachusetts
      EDGE Lab
    Nov 6, 2023

    Blood Samples in Patients With Non-small Cell Lung Cancer

    Recruiting
    • Stage III Non-Small Cell Lung Cancer AJCC v7
    • +3 more
    • Biospecimen Collection
    • Laboratory Biomarker Analysis
    • Los Angeles, California
      USC / Norris Comprehensive Cancer Center
    Nov 18, 2022

    Malaria,Falciparum, Parasitemia, Protozoan Infections Trial in Antwerpen (Artemether-Lumefantrine 20 Mg-120 Mg Oral Tablet,

    Completed
    • Malaria,Falciparum
    • +3 more
    • Artemether-Lumefantrine 20 Mg-120 Mg Oral Tablet
    • PfSPZ-DVI Challenge
    • Antwerpen, Belgium
      SGS Belgium NV Clinical Pharmacology Unit
    Sep 3, 2021

    Menopause, Elevated Blood Pressure, Hypertension Trial in Fort Collins (Blueberry Powder, Placebo Powder)

    Completed
    • Menopause
    • +3 more
    • Blueberry Powder
    • Placebo Powder
    • Fort Collins, Colorado
      Department of Food Science and Human Nutrition, Colorado State U
    Sep 9, 2022

    End-Stage Renal Disease

    Completed
    • Hemodialysis
    • Pulsevelocity
    • Tehran, Iran, Islamic Republic of
      SBMU
    Jan 27, 2022